摘要
目的：探讨缬沙坦联合培哚普利治疗糖尿病肾病的临床疗效。方法选取我院2013年3月～2014年5月收治的96例糖尿病肾病患者，将其随机分为实验组和对照组，对照组患者采用单独使用缬沙坦方法进行治疗，实验组患者在对照组方法的基础上加入培哚普利进行治疗。结果实验组采用缬沙坦和培哚普利联合治疗，实验组患者的总有效率为93.7%，明显优于对照组患者的总有效率68.9%，差异显著（P＜0.05）；同时两组UAER、Scr对比有显著差异，P＜0.05。BUN、SBP、DBP、FBG、血钾对比无显著差异，P＞0.05。结论采用缬沙坦联合培哚普利治疗糖尿病肾病效果显著，对肾组织无毒害作用，值得推广。
Objective To investigate the joint without perindopril valsartan split clinical curative effect for the treatment of diabetic nephropathy.Methods Our hospital in March 2013 ～May 2014 were treated 96 cases of diabetic nephropathy were randomly divided into experimental and control groups, the control group were treated with the use of valsartan alone method for treatment,patients in the experimental group Valerian sand Tan and perindopril treatment.Results The experimental group of valsartan and perindopril combination therapy, with a total effective rate of the experimental group were 93.7%, significantly better than the control group of patients with total efficiency of 68.9%, the difference was significant （P〈0.05）; while two UAER there are significant differences, Scr contrast,P〈0.05. BUN, SBP, DBP, FBG, potassium contrast no significant difference,P〉0.05.Conclusion Valsartan combined without perindopril captopril treatment of diabetic nephropathy effect is remarkable, for renal tissue took place, worthy of promotion.
出处
《中国卫生标准管理》
2015年第6期249-250,共2页
China Health Standard Management
关键词
缬沙坦
培哚普利
糖尿病肾病
Valsartan
Without perindopril split
Diabetic nephropathy
